It has been shown in osteosarcoma that the silencing of AMF/PGI reduces the production and secretion of TGF‐β2 and TGF‐β3 resulting in downregulation of SNAI1 that can elevate E‐cadherin expression leading to MET. Here, SNAI1 is linked to osteosarcoma.